SRT3109 structure
|
Common Name | SRT3109 | ||
---|---|---|---|---|
CAS Number | 1204707-71-0 | Molecular Weight | 475.533 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 726.6±70.0 °C at 760 mmHg | |
Molecular Formula | C18H23F2N5O4S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 393.3±35.7 °C |
Use of SRT3109SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases. |
Name | N-[2-[(2,3-difluorophenyl)methylsulfanyl]-6-[[(2R,3R)-3,4-dihydroxybutan-2-yl]amino]pyrimidin-4-yl]azetidine-1-sulfonamide |
---|---|
Synonym | More Synonyms |
Description | SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases. |
---|---|
Related Catalog | |
Target |
CXCR2:8.2 (pIC50) |
In Vitro | SRT3109 (Example 1) is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases[1]. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 726.6±70.0 °C at 760 mmHg |
Molecular Formula | C18H23F2N5O4S2 |
Molecular Weight | 475.533 |
Flash Point | 393.3±35.7 °C |
Exact Mass | 475.115936 |
PSA | 161.36000 |
LogP | 2.07 |
Vapour Pressure | 0.0±2.5 mmHg at 25°C |
Index of Refraction | 1.661 |
Storage condition | 2-8℃ |
~62% SRT3109 CAS#:1204707-71-0 |
Literature: MEGHANI, PREMJI; ROBBINS, ANDREW JAMES; STONEHOUSE, JEFFREY PAUL Patent: US2010/16275 A1, 2010 ; Location in patent: Page/Page column 12 ; |
~64% SRT3109 CAS#:1204707-71-0 |
Literature: MEGHANI, PREMJI; ROBBINS, ANDREW JAMES; STONEHOUSE, JEFFREY PAUL Patent: US2010/16275 A1, 2010 ; Location in patent: Page/Page column 14 ; |
Precursor 3 | |
---|---|
DownStream 0 |
Y0301 |
CS-0977 |
1-Azetidinesulfonamide, N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-[[(1R,2R)-2,3-dihydroxy-1-methylpropyl]amino]-4-pyrimidinyl]- |
SRT-3109 |
cc-200 |
N-(2-[(2,3-Difluorobenzyl)sulfanyl]-6-{[(2R,3R)-3,4-dihydroxy-2-butanyl]amino}-4-pyrimidinyl)-1-azetidinesulfonamide |
SRT3109 |